JP2014503001A5 - - Google Patents

Download PDF

Info

Publication number
JP2014503001A5
JP2014503001A5 JP2013550622A JP2013550622A JP2014503001A5 JP 2014503001 A5 JP2014503001 A5 JP 2014503001A5 JP 2013550622 A JP2013550622 A JP 2013550622A JP 2013550622 A JP2013550622 A JP 2013550622A JP 2014503001 A5 JP2014503001 A5 JP 2014503001A5
Authority
JP
Japan
Prior art keywords
compound
formula
mixture
salt
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013550622A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014503001A (ja
JP5993875B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/022053 external-priority patent/WO2012100179A1/en
Publication of JP2014503001A publication Critical patent/JP2014503001A/ja
Publication of JP2014503001A5 publication Critical patent/JP2014503001A5/ja
Application granted granted Critical
Publication of JP5993875B2 publication Critical patent/JP5993875B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013550622A 2011-01-21 2012-01-20 縮合アミノジヒドロチアジン誘導体の合成に有用な方法および化合物 Expired - Fee Related JP5993875B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161434849P 2011-01-21 2011-01-21
US61/434,849 2011-01-21
PCT/US2012/022053 WO2012100179A1 (en) 2011-01-21 2012-01-20 Methods and compounds useful in the synthesis of fused aminodihydrothiazine derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016041508A Division JP6087005B2 (ja) 2011-01-21 2016-03-03 縮合アミノジヒドロチアジン誘導体の合成に有用な方法および化合物

Publications (3)

Publication Number Publication Date
JP2014503001A JP2014503001A (ja) 2014-02-06
JP2014503001A5 true JP2014503001A5 (enExample) 2016-01-28
JP5993875B2 JP5993875B2 (ja) 2016-09-14

Family

ID=45563570

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013550622A Expired - Fee Related JP5993875B2 (ja) 2011-01-21 2012-01-20 縮合アミノジヒドロチアジン誘導体の合成に有用な方法および化合物
JP2016041508A Expired - Fee Related JP6087005B2 (ja) 2011-01-21 2016-03-03 縮合アミノジヒドロチアジン誘導体の合成に有用な方法および化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016041508A Expired - Fee Related JP6087005B2 (ja) 2011-01-21 2016-03-03 縮合アミノジヒドロチアジン誘導体の合成に有用な方法および化合物

Country Status (12)

Country Link
US (3) US8426584B2 (enExample)
EP (1) EP2665716B1 (enExample)
JP (2) JP5993875B2 (enExample)
CN (2) CN103502231A (enExample)
BR (1) BR112013016241A2 (enExample)
CA (1) CA2814014A1 (enExample)
ES (1) ES2624288T3 (enExample)
IL (1) IL226405A0 (enExample)
MX (1) MX2013005115A (enExample)
RU (1) RU2013138226A (enExample)
SG (2) SG191710A1 (enExample)
WO (1) WO2012100179A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0906962B8 (pt) 2008-01-18 2021-05-25 Eisai R&D Man Co Ltd composto de aminodiidrotiazina fundido
GB0912777D0 (en) 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydropyrimidone derivatives
GB0912778D0 (en) 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydro-oxazine derivatives
GB201100181D0 (en) 2011-01-06 2011-02-23 Eisai Ltd Fused aminodihydrothiazine derivatives
GB201101140D0 (en) 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives
GB201101139D0 (en) 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives
UY34278A (es) 2011-08-25 2013-04-05 Novartis Ag Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades
GB201212816D0 (en) * 2012-07-19 2012-09-05 Eisai Ltd Novel compounds
TWI639607B (zh) 2013-06-18 2018-11-01 美國禮來大藥廠 Bace抑制劑
CA2963761C (en) * 2014-10-10 2023-10-17 Eisai R&D Management Co., Ltd. Pharmaceutical composition of fused aminodihydrothiazine derivative
KR102630042B1 (ko) 2016-10-27 2024-01-29 에자이 알앤드디 매니지먼트 가부시키가이샤 알츠하이머병의 치료를 위한 항-a베타 원시섬유 항체 및 베타-세크레타제 bace1 억제제를 포함하는 조성물
WO2020023530A2 (en) 2018-07-24 2020-01-30 Eisai R&D Management Co., Ltd. Methods of treatment and prevention of alzheimer's disease

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3235551A (en) 1966-02-15 Novel derivatives of
US3227713A (en) 1966-01-04 Azine derivatives
JPH0967355A (ja) 1995-08-31 1997-03-11 Tokyo Tanabe Co Ltd チアジン誘導体、チアゾール誘導体及びそれらの製造方法
AU2001258771A1 (en) 2000-05-19 2001-11-26 Takeda Chemical Industries Ltd. -secretase inhibitors
US6562783B2 (en) 2001-05-30 2003-05-13 Neurologic, Inc. Phosphinylmethyl and phosphorylmethyl succinic and glutauric acid analogs as β-secretase inhibitors
AU2003254844A1 (en) 2002-08-09 2004-02-25 Takeda Chemical Industries, Ltd. Substituted amino compounds and use thereof
AU2003285012A1 (en) 2002-10-24 2004-05-13 Sepracor, Inc. Compositions comprising zopiclone derivatives and methods of making and using the same
JP2004149429A (ja) 2002-10-29 2004-05-27 Takeda Chem Ind Ltd インドール化合物およびその用途
DE60329316D1 (de) 2002-11-12 2009-10-29 Merck & Co Inc Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
CA2548388A1 (en) 2003-12-15 2005-06-30 Schering Corporation Heterocyclic aspartyl protease inhibitors
JP2007530696A (ja) 2004-03-30 2007-11-01 メルク エンド カムパニー インコーポレーテッド アスパラギン酸プロテアーゼ阻害剤として有用な2−アミノチアゾール化合物
PE20060664A1 (es) 2004-09-15 2006-08-04 Novartis Ag Amidas biciclicas como inhibidores de cinasa
CN101084198A (zh) 2004-10-15 2007-12-05 阿斯利康(瑞典)有限公司 取代的氨基-嘧啶酮及其用途
US20090221579A1 (en) 2004-10-15 2009-09-03 Jeffrey Scott Albert Substituted Amino-Compounds and Uses Thereof
WO2006078577A1 (en) 2005-01-19 2006-07-27 Merck & Co., Inc. Tertiary carbinamines having substituted heterocycles, which are active as inhibitors of beta-secretase, for the treatment of alzheimer's disease
WO2006138264A2 (en) 2005-06-14 2006-12-28 Schering Corporation Aspartyl protease inhibitors
CA2615656A1 (en) 2005-07-18 2007-01-25 Merck & Co., Inc. Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
ES2537898T3 (es) 2005-10-25 2015-06-15 Shionogi & Co., Ltd. Derivados de aminotiazolidina y aminotetrahidrotiazepina como inhibidores de BACE 1
JP2009532464A (ja) 2006-04-05 2009-09-10 アストラゼネカ・アクチエボラーグ 2−アミノピリミジン−4−オン及びAβ−関連の病理を治療又は予防するためのその使用
JP5117382B2 (ja) 2006-05-31 2013-01-16 第一三共株式会社 7員環化合物の製造方法
MX2009006228A (es) 2006-12-12 2009-06-22 Schering Corp Inhibidores de aspartil proteasa.
EP2151435A4 (en) * 2007-04-24 2011-09-14 Shionogi & Co PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
AU2008245082B8 (en) 2007-04-24 2012-09-13 Shionogi & Co., Ltd. Aminodihydrothiazine derivatives substituted with a cyclic group
EP2151436B1 (en) 2007-05-29 2013-04-24 Santen Pharmaceutical Co., Ltd Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity
PE20091236A1 (es) 2007-11-22 2009-09-16 Astrazeneca Ab Derivados de pirimidina como immunomoduladores de tlr7
BRPI0906962B8 (pt) 2008-01-18 2021-05-25 Eisai R&D Man Co Ltd composto de aminodiidrotiazina fundido
TWI431004B (zh) 2008-05-02 2014-03-21 Lilly Co Eli Bace抑制劑
WO2010013302A1 (ja) 2008-07-28 2010-02-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 スピロアミノジヒドロチアジン誘導体
AU2009277485B2 (en) 2008-07-28 2013-05-02 Eisai R&D Management Co., Ltd. Spiroaminodihydrothiazine derivatives
KR20110076965A (ko) 2008-09-30 2011-07-06 에자이 알앤드디 매니지먼트 가부시키가이샤 신규한 축합 아미노 디하이드로티아진 유도체
AR077277A1 (es) * 2009-07-09 2011-08-17 Lilly Co Eli Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer
GB0912778D0 (en) * 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydro-oxazine derivatives
GB0912777D0 (en) 2009-07-22 2009-08-26 Eisai London Res Lab Ltd Fused aminodihydropyrimidone derivatives
MX2012015135A (es) 2010-07-01 2013-05-06 Amgen Inc Compuestos heterociclicos y su uso como inhibidores de la actividad pi3k.
GB201101140D0 (en) 2011-01-21 2011-03-09 Eisai Ltd Fused aminodihydrothiazine derivatives

Similar Documents

Publication Publication Date Title
JP2016121177A5 (enExample)
RU2013138226A (ru) Способы и соединения, пригодные для получения конденсированных аминодигидротиазиновых производных
WO2007102499A1 (ja) 4-オキソキノリン化合物の製造方法
JP2014525414A (ja) ベンゾオキサジノンをアミンと反応させることによるテトラゾール置換アントラニル酸ジアミド誘導体の製造方法
JP2014511387A5 (enExample)
CN103214455B (zh) 一种比拉斯汀的制备方法
CN105829284A (zh) 制备金刚烷甲酰胺类化合物的方法
WO2018032586A1 (zh) 一种3-(二氟甲基)-1-甲基-1h-吡唑-4-羧酸的合成方法及其中间体
JP6251197B2 (ja) 置換フェニルプロパノンを調製するためのプロセス
CN105418502B (zh) 一种用于合成帕罗西汀的中间体及其制备方法和用途
WO2018184196A1 (zh) 一种制备2-芳基丙二酰胺的方法及其应用
JP2014031512A5 (enExample)
JP7027541B2 (ja) ジシクロヘキサンジカルボン酸ジエステルの製造方法およびジシクロヘキサンジカルボン酸の製造方法
CN108689874B (zh) 一种制备2-芳基丙二酰胺的方法及其应用
JP2011513358A5 (enExample)
JP6809485B2 (ja) 酸ハライド溶液の製造方法、及びモノエステル化合物の製造方法
JP2013136561A (ja) 2,6−ジエチル−4−メチルフェニル酢酸の製造方法
JPWO2017056501A1 (ja) 酸ハライド溶液の製造方法、混合溶液、及びモノエステル化合物の製造方法
WO2014103812A1 (ja) ピラゾール化合物の結晶の製造方法
CN102382070A (zh) N',n'',n''',n''''-四苄基环烯化合物的制备方法
CN1330636C (zh) 盐酸替罗非班中间体的合成方法
CN102643273B (zh) 一种伊潘立酮的制备方法
CN110437093A (zh) 一种(s)-5-氟-3-甲基异苯并呋喃-3-酮的乙酰化中间体的制备方法
JP2014525897A5 (enExample)
JP4905764B2 (ja) ビシクロヘキサン誘導体及びその製造方法